Barely Significant
← all excerpts

Treatment satisfaction with molidustat in CKD-related anemia in non-dialysis patients: a post-hoc analysis of two clinical trials.

Clin Exp Nephrol · 2023 · PMC10352152 · PMID 37095342

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

nominally significantp < 0.05actually significant
Patients in the molidustat and darbepoetin groups reported a nominally significant improvement in effectiveness domain scores at 12 and 24 weeks ( p < 0.05).

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.